Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Olsson

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Alzheimer'S Disease Reports|June 11, 2021
Plasma Amyloid-β in Relation to Antibodies Against Herpes Simplex Virus, Cytomegalovirus, and <i>Chlamydophila pneumoniae</i>Karin Lopatko Lindman, Bodil Weidung, Jan Olsson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 17, 2021
Antiviral treatment associated with reduced risk of clinical Alzheimer's disease-A nested case-control studyEva-Stina Hemmingsson, Ellen Hjelmare, Bodil Weidung, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 11, 2012
Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolatesJan Olsson, Sabina Davidsson, Magnus Unemo, et al.
Journal of Clinical Microbiology|September 21, 2007
Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assayOleg A Alexeyev, Ingrid Marklund, Beverley Shannon, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's diseaseBodil Weidung, Eva-Stina Hemmingsson, Jan Olsson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in SwedenKarin Lopatko Lindman, Eva-Stina Hemmingsson, Bodil Weidung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2020
Correction: An Ig γ Marker Genotype Is a Strong Risk Factor for Alzheimer Disease, Independent of Apolipoprotein E ε4 GenotypeJanardan P Pandey, Jan Olsson, Bodil Weidung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2020
An Ig γ Marker Genotype Is a Strong Risk Factor for Alzheimer Disease, Independent of Apolipoprotein E ε4 GenotypeJanardan P Pandey, Jan Olsson, Bodil Weidung, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 11, 2020
A genetic signature including apolipoprotein Eε4 potentiates the risk of herpes simplex-associated Alzheimer's diseaseKarin Lopatko Lindman, Bodil Weidung, Jan Olsson, et al.
Scientific Reports|August 2, 2022
PILRA polymorphism modifies the effect of APOE4 and GM17 on Alzheimer's disease riskKarin Lopatko Lindman, Caroline Jonsson, Bodil Weidung, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Alzheimer'S Disease Reports|June 11, 2021
Plasma Amyloid-β in Relation to Antibodies Against Herpes Simplex Virus, Cytomegalovirus, and <i>Chlamydophila pneumoniae</i>Karin Lopatko Lindman, Bodil Weidung, Jan Olsson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 17, 2021
Antiviral treatment associated with reduced risk of clinical Alzheimer's disease-A nested case-control studyEva-Stina Hemmingsson, Ellen Hjelmare, Bodil Weidung, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 11, 2012
Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolatesJan Olsson, Sabina Davidsson, Magnus Unemo, et al.
Journal of Clinical Microbiology|September 21, 2007
Direct visualization of Propionibacterium acnes in prostate tissue by multicolor fluorescent in situ hybridization assayOleg A Alexeyev, Ingrid Marklund, Beverley Shannon, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's diseaseBodil Weidung, Eva-Stina Hemmingsson, Jan Olsson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|February 22, 2021
Herpesvirus infections, antiviral treatment, and the risk of dementia-a registry-based cohort study in SwedenKarin Lopatko Lindman, Eva-Stina Hemmingsson, Bodil Weidung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 31, 2020
Correction: An Ig γ Marker Genotype Is a Strong Risk Factor for Alzheimer Disease, Independent of Apolipoprotein E ε4 GenotypeJanardan P Pandey, Jan Olsson, Bodil Weidung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2020
An Ig γ Marker Genotype Is a Strong Risk Factor for Alzheimer Disease, Independent of Apolipoprotein E ε4 GenotypeJanardan P Pandey, Jan Olsson, Bodil Weidung, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 11, 2020
A genetic signature including apolipoprotein Eε4 potentiates the risk of herpes simplex-associated Alzheimer's diseaseKarin Lopatko Lindman, Bodil Weidung, Jan Olsson, et al.
Scientific Reports|August 2, 2022
PILRA polymorphism modifies the effect of APOE4 and GM17 on Alzheimer's disease riskKarin Lopatko Lindman, Caroline Jonsson, Bodil Weidung, et al.
Pageof 4